AIM ImmunoTech Inc (NYSE American:AIM)

2.05
Delayed Data
As of Mar 05
 -0.04 / -1.91%
Today’s Change
1.60
Today|||52-Week Range
7.11
+14.53%
Year-to-Date
No recent news for AIM ImmunoTech Inc.

Today’s Trading

Previous close2.09
Today’s open2.05
Day’s range1.96 - 2.09
Volume1,697,349
Average volume (3 months)2,887,371
Market cap$105.0M
Data as of 3:59pm ET, 03/05/2021

Growth & Valuation

Earnings growth (last year)+73.22%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-61.85%
P/E ratio1.4
Price/Sales14.15
Price/Book2.21

Competitors

 Today’s
change
Today’s
% change
AGEAgeX Therapeutics In...-0.01-0.45%
GLMDGalmed Pharmaceutica...-0.02-0.56%
----
DAREDare Bioscience Inc+0.04+2.12%
Data as of 3:59pm ET, 03/05/2021

Financials

Next reporting dateApril 5, 2021
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$140.0K
Annual profit (last year)-$9.5M
Net profit margin-6,809.29%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Ocala, Florida

Forecasts